BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuipers EJ, Spaander MC. Natural History of Barrett's Esophagus. Dig Dis Sci 2018;63:1997-2004. [PMID: 29905908 DOI: 10.1007/s10620-018-5161-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Agha YH, Srinivasan S, Hyder J, Wuthnow C, Taleb A, Tofteland N, Kilgore W, Salyers W. WATS3D versus forceps biopsy in screening for Barrett's esophagus: experience in community endoscopy centers. Ann Gastroenterol 2021;34:164-8. [PMID: 33654354 DOI: 10.20524/aog.2020.0564] [Reference Citation Analysis]
2 Mikolašević I, Bokun T, Filipec Kanižaj T. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma - where do we stand? Croat Med J 2018;59:97-9. [PMID: 29972731 DOI: 10.3325/cmj.2018.59.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Dugalic P, Djuranovic S, Pavlovic-Markovic A, Dugalic V, Tomasevic R, Gluvic Z, Obradovic M, Bajic V, Isenovic ER. Proton Pump Inhibitors and Radiofrequency Ablation for Treatment of Barrett's Esophagus. Mini Rev Med Chem 2020;20:975-87. [PMID: 31644405 DOI: 10.2174/1389557519666191015203636] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ieni A, Cardia R, Pizzimenti C, Zeppa P, Tuccari G. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies. J Pers Med 2020;10:E10. [PMID: 32098203 DOI: 10.3390/jpm10010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Maitra I, Date RS, Martin FL. Towards screening Barrett's oesophagus: current guidelines, imaging modalities and future developments.Clin J Gastroenterol. 2020;13:635-649. [PMID: 32495144 DOI: 10.1007/s12328-020-01135-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moulla Y, Lyros O, Mehdorn M, Lange U, Hamade H, Thieme R, Hoffmeister A, Feisthammel J, Blüher M, Jansen-winkeln B, Gockel I, Dietrich A. Preoperative Upper-GI Endoscopy Prior to Bariatric Surgery: Essential or Optional? OBES SURG 2020;30:2076-84. [DOI: 10.1007/s11695-020-04485-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Peleg N, Schmilovitz-Weiss H, Shamah S, Schwartz A, Dotan I, Sapoznikov B. Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus. Endoscopy 2021;53:774-81. [PMID: 33075822 DOI: 10.1055/a-1292-8747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Putra J, Arva NC, Tan SY, Melin-Aldana H, Bass LM, Mitchell PD, Fox VL, Goldsmith JD. Barrett Esophagus and Intestinal Metaplasia of the Gastroesophageal Junction in Children: A Clinicopathologic Study. J Pediatr Gastroenterol Nutr 2020;70:562-7. [PMID: 31977949 DOI: 10.1097/MPG.0000000000002640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
9 Correia ACP, Calpe S, Mostafavi N, Hoefnagel SJM, Sancho-Serra MDC, de Koning PS, Krishnadath KK. Detection of circulating BMP5 as a risk factor for Barrett's esophagus. Sci Rep 2020;10:15579. [PMID: 32968094 DOI: 10.1038/s41598-020-70760-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Saito T, Ohashi S, Mizumoto A, Muto M. Patient-derived tumor models of esophageal cancer. Enzymes 2019;46:97-111. [PMID: 31727279 DOI: 10.1016/bs.enz.2019.10.003] [Reference Citation Analysis]
11 Otaki F, Iyer PG. Gastroesophageal Reflux Disease and Barrett Esophagus in the Elderly. Clin Geriatr Med 2021;37:17-29. [PMID: 33213770 DOI: 10.1016/j.cger.2020.08.003] [Reference Citation Analysis]
12 Yin F, Hernandez Gonzalo D, Lai J, Liu X. Histopathology of Barrett’s Esophagus and Early-Stage Esophageal Adenocarcinoma: An Updated Review. GastrointestDisord 2018;1:147-63. [DOI: 10.3390/gidisord1010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Marques de Sá I, Marcos P, Sharma P, Dinis-Ribeiro M. The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J 2020;8:1086-105. [PMID: 32631176 DOI: 10.1177/2050640620939376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Stingl C, Bureo Gonzalez A, Güzel C, Phoa KYN, Doukas M, Breimer GE, Meijer SL, Bergman JJ, Luider TM. Alteration of protein expression and spliceosome pathway activity during Barrett's carcinogenesis. J Gastroenterol 2021;56:791-807. [PMID: 34227026 DOI: 10.1007/s00535-021-01802-2] [Reference Citation Analysis]